-
1
-
-
0037152667
-
Oral cancer treatment: Developments in chemotherapy and beyond
-
DOI 10.1038/sj.bjc.6600591
-
O'Neill VJ, Twelves CJ (2002) Oral cancer treatment: developments in chemotherapy and beyond. Br J Cancer 87(9):933-937. doi: 10.1038/sj.bjc.6600591 (Pubitemid 35305640)
-
(2002)
British Journal of Cancer
, vol.87
, Issue.9
, pp. 933-937
-
-
O'Neill, V.J.1
Twelves, C.J.2
-
2
-
-
38849106122
-
Effective oral chemotherapy for breast cancer: Pill ars of strength
-
DOI 10.1093/annonc/mdm285
-
Findlay M, von Minckwitz G, Wardley A (2008) Effective oral chemotherapy for breast cancer: pillars of strength. Ann Oncol 19(2):212-222. doi: 10.1093/annonc/mdm285 (Pubitemid 351201700)
-
(2008)
Annals of Oncology
, vol.19
, Issue.2
, pp. 212-222
-
-
Findlay, M.1
Von Minckwitz, G.2
Wardley, A.3
-
3
-
-
0031017851
-
Patient preferences for oral versus intravenous palliative chemotherapy
-
Liu G, Franssen E, Fitch MI, Warner E (1997) Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol 15(1):110-115 (Pubitemid 27021524)
-
(1997)
Journal of Clinical Oncology
, vol.15
, Issue.1
, pp. 110-115
-
-
Liu, G.1
Franssen, E.2
Fitch, M.I.3
Warner, E.4
-
4
-
-
24944449437
-
Modulation of oral drug bioavailability: From preclinical mechanism to therapeutic application
-
DOI 10.1081/CNV-58823
-
Kuppens IE, Breedveld P, Beijnen JH, Schellens JH (2005) Modulation of oral drug bioavailability: from preclinical mechanism to therapeutic application. Cancer Invest 23(5):443-464 (Pubitemid 41324362)
-
(2005)
Cancer Investigation
, vol.23
, Issue.5
, pp. 443-464
-
-
Kuppens, I.E.L.M.1
Breedveld, P.2
Beijnen, J.H.3
Schellens, J.H.M.4
-
5
-
-
78349307556
-
Anticancer oral therapy: Emerging related issues
-
10.1016/j.ctrv.2010.04.005 20570443 10.1016/j.ctrv.2010.04.005
-
Banna GL, Collova E, Gebbia V, Lipari H, Giuffrida P, Cavallaro S, Condorelli R, Buscarino C, Tralongo P, Ferrau F (2010) Anticancer oral therapy: emerging related issues. Cancer Treat Rev 36(8):595-605. doi: 10.1016/j.ctrv.2010.04.005
-
(2010)
Cancer Treat Rev
, vol.36
, Issue.8
, pp. 595-605
-
-
Banna, G.L.1
Collova, E.2
Gebbia, V.3
Lipari, H.4
Giuffrida, P.5
Cavallaro, S.6
Condorelli, R.7
Buscarino, C.8
Tralongo, P.9
Ferrau, F.10
-
6
-
-
34047202064
-
Oral vinorelbine: Role in the management of metastatic breast cancer
-
DOI 10.2165/00003495-200767050-00002
-
Aapro MS, Conte P, Esteban Gonzalez E, Trillet-Lenoir V (2007) Oral vinorelbine: role in the management of metastatic breast cancer. Drugs 67(5):657-667 (Pubitemid 46535641)
-
(2007)
Drugs
, vol.67
, Issue.5
, pp. 657-667
-
-
Aapro, M.S.1
Conte, P.2
Gonzalez, E.E.3
Trillet-Lenoir, V.4
-
7
-
-
0036159485
-
Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: A randomised crossover trial in advanced colorectal cancer
-
DOI 10.1016/S0959-8049(01)00371-9, PII S0959804901003719
-
Borner MM, Schoffski P, de Wit R, Caponigro F, Comella G, Sulkes A, Greim G, Peters GJ, van der Born K, Wanders J, de Boer RF, Martin C, Fumoleau P (2002) Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer. Eur J Cancer 38(3):349-358 (Pubitemid 34121962)
-
(2002)
European Journal of Cancer
, vol.38
, Issue.3
, pp. 349-358
-
-
Borner, M.M.1
Schoffski, P.2
De Wit, R.3
Caponigro, F.4
Comella, G.5
Sulkes, A.6
Greim, G.7
Peters, G.J.8
Van Der Born, K.9
Wanders, J.10
De Boer, R.F.11
Martin, C.12
Fumoleau, P.13
-
8
-
-
24644482057
-
Perception that oral anticancer treatments are less efficacious: Development of a questionnaire to assess the possible prejudices of patients with cancer
-
DOI 10.1007/s10549-005-3376-y
-
Catania C, Didier F, Leon ME, Sbanotto A, Mariani L, Nole F, Leida E, Rocca A, De Pas T, Goldhirsch A (2005) Perception that oral anticancer treatments are less efficacious: development of a questionnaire to assess the possible prejudices of patients with cancer. Breast Cancer Res Treat 92(3):265-272. doi: 10.1007/s10549-005-3376-y (Pubitemid 41279636)
-
(2005)
Breast Cancer Research and Treatment
, vol.92
, Issue.3
, pp. 265-272
-
-
Catania, C.1
Didier, F.2
Leon, M.E.3
Sbanotto, A.4
Mariani, L.5
Nole, F.6
Leida, E.7
Rocca, A.8
De Pas, T.9
Goldhirsch, A.10
-
9
-
-
34247553690
-
Overview of the changing paradigm in cancer treatment: Oral chemotherapy
-
DOI 10.2146/ajhp070035
-
Aisner J (2007) Overview of the changing paradigm in cancer treatment: oral chemotherapy. Am J Health Syst Pharm 64(9 Suppl 5):S4-S7. doi: 10.2146/ajhp070035 (Pubitemid 46676685)
-
(2007)
American Journal of Health-System Pharmacy
, vol.64
, Issue.9 SUPPL.
-
-
Aisner, J.1
-
10
-
-
14944385553
-
Pisani P (2005) Global cancer statistics
-
10.3322/canjclin.55.2.74
-
Parkin DM, Bray F, Ferlay J (2002) Pisani P (2005) Global cancer statistics. CA Cancer J Clin 55(2):74-108
-
(2002)
CA Cancer J Clin
, vol.55
, Issue.2
, pp. 74-108
-
-
Parkin, D.M.1
Bray, F.2
Ferlay, J.3
-
11
-
-
31444447160
-
Extending survival with chemotherapy in metastatic breast cancer
-
DOI 10.1634/theoncologist.10-90003-20
-
O'Shaughnessy J (2005) Extending survival with chemotherapy in metastatic breast cancer. Oncologist 10(Suppl 3):20-29. doi: 10.1634/theoncologist.10- 90003-20 (Pubitemid 43152727)
-
(2005)
Oncologist
, vol.10
, Issue.SUPPL. 3
, pp. 20-29
-
-
O'Shaughnessy, J.1
-
12
-
-
0035049886
-
Chemotherapy of metastatic breast cancer: What to expect in 2001 and beyond
-
DOI 10.1634/theoncologist.6-2-133
-
Esteva FJ, Valero V, Pusztai L, Boehnke-Michaud L, Buzdar AU, Hortobagyi GN (2001) Chemotherapy of metastatic breast cancer: what to expect in 2001 and beyond. Oncologist 6(2):133-146 (Pubitemid 32323452)
-
(2001)
Oncologist
, vol.6
, Issue.2
, pp. 133-146
-
-
Esteva, F.J.1
Valero, V.2
Pusztai, L.3
Boehnke-Michaud, L.4
Buzdar, A.U.5
Hortobagyi, G.N.6
-
13
-
-
46949103546
-
Metastatic breast cancer: The treatment challenge
-
DOI 10.3816/CBC.2008.n.025
-
Jones SE (2008) Metastatic breast cancer: the treatment challenge. Clin Breast Cancer 8(3):224-233. doi: 10.3816/CBC.2008.n.025 (Pubitemid 351962143)
-
(2008)
Clinical Breast Cancer
, vol.8
, Issue.3
, pp. 224-233
-
-
Jones, S.E.1
-
14
-
-
33846436108
-
Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program
-
DOI 10.1634/theoncologist.12-1-20
-
Hayat MJ, Howlader N, Reichman ME, Edwards BK (2007) Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 12(1):20-37. doi: 10.1634/theoncologist.12-1-20 (Pubitemid 46143500)
-
(2007)
Oncologist
, vol.12
, Issue.1
, pp. 20-37
-
-
Hayat, M.J.1
Howlader, N.2
Reichman, M.E.3
Edwards, B.K.4
-
15
-
-
77956333064
-
Algorithms for the treatment of patients with metastatic breast cancer and prior exposure to taxanes and anthracyclines
-
10.3816/CBC.2010.s.008 20805067 10.3816/CBC.2010.s.008 1:CAS:528:DC%2BC3cXht1Whu7nP
-
Comen EA, Fornier MN (2010) Algorithms for the treatment of patients with metastatic breast cancer and prior exposure to taxanes and anthracyclines. Clin Breast Cancer 10(Suppl 2):S7-19. doi: 10.3816/CBC.2010.s.008
-
(2010)
Clin Breast Cancer
, vol.10
, Issue.SUPPL. 2
, pp. 7-19
-
-
Comen, E.A.1
Fornier, M.N.2
-
16
-
-
33847288165
-
Second consensus on medical treatment of metastatic breast cancer
-
DOI 10.1093/annonc/mdl155
-
Beslija S, Bonneterre J, Burstein H, Cocquyt V, Gnant M, Goodwin P, Heinemann V, Jassem J, Kostler WJ, Krainer M, Menard S, Petit T, Petruzelka L, Possinger K, Schmid P, Stadtmauer E, Stockler M, Van Belle S, Vogel C, Wilcken N, Wiltschke C, Zielinski CC, Zwierzina H (2007) Second consensus on medical treatment of metastatic breast cancer. Ann Oncol 18(2):215-225. doi: 10.1093/annonc/mdl155 (Pubitemid 46323085)
-
(2007)
Annals of Oncology
, vol.18
, Issue.2
, pp. 215-225
-
-
Beslija, S.1
Bonneterre, J.2
Burstein, H.3
Cocquyt, V.4
Gnant, M.5
Goodwin, P.6
Heinemann, V.7
Jassem, J.8
Kostler, W.J.9
Krainer, M.10
Menard, S.11
Petit, T.12
Petruzelka, L.13
Possinger, K.14
Schmid, P.15
Stadtmauer, E.16
Stockler, M.17
Van Belle, S.18
Vogel, C.19
Wilcken, N.20
Wiltschke, C.21
Zielinski, C.C.22
Zwierzina, H.23
more..
-
17
-
-
26444607816
-
Survival of metastatic breast carcinoma patients over a 20-year period: A retrospective analysis based on individual patient data from six consecutive studies
-
DOI 10.1002/cncr.21359
-
Gennari A, Conte P, Rosso R, Orlandini C, Bruzzi P (2005) Survival of metastatic breast carcinoma patients over a 20-year period: a retrospective analysis based on individual patient data from six consecutive studies. Cancer 104(8):1742-1750. doi: 10.1002/cncr.21359 (Pubitemid 41437440)
-
(2005)
Cancer
, vol.104
, Issue.8
, pp. 1742-1750
-
-
Gennari, A.1
Conte, P.2
Rosso, R.3
Orlandini, C.4
Bruzzi, P.5
-
18
-
-
34548187711
-
The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer
-
DOI 10.1002/cncr.22867
-
Chia SK, Speers CH, D'Yachkova Y, Kang A, Malfair-Taylor S, Barnett J, Coldman A, Gelmon KA, O'Reilly SE, Olivotto IA (2007) The impact of new chemotherapeutic and hormone agents on survival in a population-based cohort of women with metastatic breast cancer. Cancer 110(5):973-979. doi: 10.1002/cncr.22867 (Pubitemid 47312861)
-
(2007)
Cancer
, vol.110
, Issue.5
, pp. 973-979
-
-
Chia, S.K.1
Speers, C.H.2
D'Yachkova, Y.3
Kang, A.4
Malfair-Taylor, S.5
Barnett, J.6
Coldman, A.7
Gelmon, K.A.8
O'Reilly, S.E.9
Olivotto, I.A.10
-
19
-
-
0034079089
-
Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer
-
DOI 10.1053/ctrv.1999.0161
-
Stockler M, Wilcken NR, Ghersi D, Simes RJ (2000) Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer. Cancer Treat Rev 26(3):151-168. doi: 10.1053/ctrv.1999.0161 (Pubitemid 30330662)
-
(2000)
Cancer Treatment Reviews
, vol.26
, Issue.3
, pp. 151-168
-
-
Stockler, M.1
Wilcken, N.R.C.2
Ghersi, D.3
Simes, R.J.4
-
20
-
-
79952087724
-
How long have i got? Estimating typical, best-case, and worst-case scenarios for patients starting first-line chemotherapy for metastatic breast cancer: A systematic review of recent randomized trials
-
10.1200/JCO.2010.30.2174 21189397 10.1200/JCO.2010.30.2174
-
Kiely BE, Soon YY, Tattersall MH, Stockler MR (2011) How long have I got? Estimating typical, best-case, and worst-case scenarios for patients starting first-line chemotherapy for metastatic breast cancer: a systematic review of recent randomized trials. J Clin Oncol 29(4):456-463. doi: 10.1200/JCO.2010.30. 2174
-
(2011)
J Clin Oncol
, vol.29
, Issue.4
, pp. 456-463
-
-
Kiely, B.E.1
Soon, Y.Y.2
Tattersall, M.H.3
Stockler, M.R.4
-
21
-
-
70349260426
-
Single agent versus combination chemotherapy for metastatic breast cancer
-
10.1002/14651858.CD003372.pub3 19370586
-
Carrick S, Parker S, Thornton CE, Ghersi D, Simes J, Wilcken N (2009) Single agent versus combination chemotherapy for metastatic breast cancer. Cochrane Database Syst Rev 2:CD003372. doi: 10.1002/14651858.CD003372.pub3
-
(2009)
Cochrane Database Syst Rev
, vol.2
, pp. 003372
-
-
Carrick, S.1
Parker, S.2
Thornton, C.E.3
Ghersi, D.4
Simes, J.5
Wilcken, N.6
-
23
-
-
84866597106
-
Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
-
10.1093/annonc/mds232 22997442 10.1093/annonc/mds232
-
Cardoso F, Harbeck N, Fallowfield L, Kyriakides S, Senkus E (2012) Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii11-vii19. doi: 10.1093/annonc/mds232
-
(2012)
Ann Oncol
, vol.23
, Issue.SUPPL. 7
-
-
Cardoso, F.1
Harbeck, N.2
Fallowfield, L.3
Kyriakides, S.4
Senkus, E.5
-
24
-
-
84856031837
-
Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: Joint analysis of 2 consecutive prospective phase II trials
-
10.1016/j.clbc.2011.11.001 22154360 10.1016/j.clbc.2011.11.001 1:CAS:528:DC%2BC38Xht1OnsLY%3D
-
Strada MR, Palumbo R, Bernardo A, Riccardi A, Teragni C, Poggi G, Frascaroli M, Amatu A, Montagna B, Sottotetti F, Tagliaferri B, Bernardo G (2012) Intravenous or oral vinorelbine plus capecitabine as first-line treatment in HER2- metastatic breast cancer: joint analysis of 2 consecutive prospective phase II trials. Clin Breast Cancer 12(1):30-39. doi: 10.1016/j.clbc.2011.11.001
-
(2012)
Clin Breast Cancer
, vol.12
, Issue.1
, pp. 30-39
-
-
Strada, M.R.1
Palumbo, R.2
Bernardo, A.3
Riccardi, A.4
Teragni, C.5
Poggi, G.6
Frascaroli, M.7
Amatu, A.8
Montagna, B.9
Sottotetti, F.10
Tagliaferri, B.11
Bernardo, G.12
-
25
-
-
77954500272
-
Capecitabine and Vinorelbine as an All-Oral Chemotherapy in HER2-Negative Locally Advanced and Metastatic Breast Cancer
-
10.1159/000314214
-
Gampenrieder SP, Bartsch R, Matzneller P, Pluschnig U, Dubsky P, Gnant MX, Zielinski CC, Steger GG (2010) Capecitabine and Vinorelbine as an All-Oral Chemotherapy in HER2-Negative Locally Advanced and Metastatic Breast Cancer. Breast Care (Basel) 5(3):158-162
-
(2010)
Breast Care (Basel)
, vol.5
, Issue.3
, pp. 158-162
-
-
Gampenrieder, S.P.1
Bartsch, R.2
Matzneller, P.3
Pluschnig, U.4
Dubsky, P.5
Gnant, M.X.6
Zielinski, C.C.7
Steger, G.G.8
-
26
-
-
33847138943
-
Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: Final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial
-
DOI 10.1016/S1470-2045(07)70041-4, PII S1470204507700414
-
Martin M, Ruiz A, Munoz M, Balil A, Garcia-Mata J, Calvo L, Carrasco E, Mahillo E, Casado A, Garcia-Saenz JA, Escudero MJ, Guillem V, Jara C, Ribelles N, Salas F, Soto C, Morales-Vasquez F, Rodriguez CA, Adrover E, Mel JR (2007) Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial. Lancet Oncol 8(3):219-225. doi: 10.1016/S1470-2045(07)70041-4 (Pubitemid 46291704)
-
(2007)
Lancet Oncology
, vol.8
, Issue.3
, pp. 219-225
-
-
Martin, M.1
Ruiz, A.2
Munoz, M.3
Balil, A.4
Garcia-Mata, J.5
Calvo, L.6
Carrasco, E.7
Mahillo, E.8
Casado, A.9
Garcia-Saenz, J.A.10
Escudero, M.J.11
Guillem, V.12
Jara, C.13
Ribelles, N.14
Salas, F.15
Soto, C.16
Morales-Vasquez, F.17
Rodriguez, C.A.18
Adrover, E.19
Mel, J.R.20
more..
-
27
-
-
41549104608
-
Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: Findings from the EORTC 10001 randomized phase II trial
-
DOI 10.1016/j.breast.2007.09.002, PII S0960977607001932
-
Pajk B, Cufer T, Canney P, Ellis P, Cameron D, Blot E, Vermorken J, Coleman R, Marreaud S, Bogaerts J, Basaran G, Piccart M (2008) Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: findings from the EORTC 10001 randomized phase II trial. Breast 17(2):180-185. doi: 10.1016/j.breast.2007.09. 002 (Pubitemid 351467955)
-
(2008)
Breast
, vol.17
, Issue.2
, pp. 180-185
-
-
Pajk, B.1
Cufer, T.2
Canney, P.3
Ellis, P.4
Cameron, D.5
Blot, E.6
Vermorken, J.7
Coleman, R.8
Marreaud, S.9
Bogaerts, J.10
Basaran, G.11
Piccart, M.12
-
28
-
-
0038473927
-
Flavopiridol in untreated or relapsed mantle-cell lymphoma: Results of a phase II study of the National Cancer Institute of Canada Clinical Trials Group
-
DOI 10.1200/jco.2003.09.057
-
Freyer G, Delozier T, Lichinister M, Gedouin D, Bougnoux P, His P, Imadalou K, Trillet-Lenoir V (2003) Phase II study of oral vinorelbine in first-line advanced breast cancer chemotherapy. J Clin Oncol 21(1):35-40. doi: 10.1200/jco.2003.09.057 (Pubitemid 46638586)
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.9
, pp. 1740-1745
-
-
Kouroukis, C.T.1
Belch, A.2
Crump, M.3
Eisenhauer, E.4
Gascoyne, R.D.5
Meyer, R.6
Lohmann, R.7
Lopez, P.8
Powers, J.9
Turner, R.10
Connors, J.M.11
-
29
-
-
84856348745
-
Efficacy and safety of oral vinorelbine in first or second-line metastatic breast cancer
-
Blancas I, Morales S, Diaz N, Barnadas A, Gonzalvez ML, del Barco S, Lopez de Ceballos MH, Perez FJ, Llombart- Cussac A (2010) Efficacy and safety of oral vinorelbine in first or second-line metastatic breast cancer. J Clin Oncol 28 (15 s)
-
(2010)
J Clin Oncol
, vol.28
, Issue.15
-
-
Blancas, I.1
Morales, S.2
Diaz, N.3
Barnadas, A.4
Gonzalvez, M.L.5
Del Barco, S.6
Lopez De Ceballos, M.H.7
Perez, F.J.8
Llombart- Cussac, A.9
-
30
-
-
31544457782
-
Efficacy and safety of navelbine oral (NVBO) in first line metastatic breast cancer (MBC)
-
10.1016/S0959-8049(01)81205-3
-
Amadori D, Koralewski P, Tekiela A, Ruiz Simon A, Llombart Cussac A, Sommer H, Schindlbeck C, Maheut K, Lafaye de Micheaux S (2001) Efficacy and safety of navelbine oral (NVBO) in first line metastatic breast cancer (MBC). Eur J Cancer 27(Suppl 6):195
-
(2001)
Eur J Cancer
, vol.27
, Issue.SUPPL. 6
, pp. 195
-
-
Amadori, D.1
Koralewski, P.2
Tekiela, A.3
Ruiz Simon, A.4
Llombart Cussac, A.5
Sommer, H.6
Schindlbeck, C.7
Maheut, K.8
Lafaye De Micheaux, S.9
-
31
-
-
0032465059
-
Breast cancer in the eastern province of Saudi Arabia
-
Ibrahim EM, al-Mulhim FA, al-Amri A, al-Muhanna FA, Ezzat AA, Stuart RK, Ajarim D (1998) Breast cancer in the eastern province of Saudi Arabia. Med Oncol 15(4):241-247 (Pubitemid 29049188)
-
(1998)
Medical Oncology
, vol.15
, Issue.4
, pp. 241-247
-
-
Ibrahim, E.M.1
Al-Mulhim, F.A.2
Al-Amri, A.3
Ai-Muhanna, F.A.4
Ezzat, A.A.5
Stuart, R.K.6
Ajarim, D.7
-
32
-
-
0032776863
-
Locally advanced breast cancer in Saudi Arabia: High frequency of stage III in a young population
-
Ezzat AA, Ibrahim EM, Raja MA, Al-Sobhi S, Rostom A, Stuart RK (1999) Locally advanced breast cancer in Saudi Arabia: high frequency of stage III in a young population. Med Oncol 16(2):95-103 (Pubitemid 29349855)
-
(1999)
Medical Oncology
, vol.16
, Issue.2
, pp. 95-103
-
-
Ezzat, A.A.1
Ibrahim, E.M.2
Raja, M.A.3
Al-Sobhi, S.4
Rostom, A.5
Stuart, R.K.6
-
33
-
-
34548141828
-
Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab
-
DOI 10.1093/jnci/djm086
-
Scappaticci FA, Skillings JR, Holden SN, Gerber HP, Miller K, Kabbinavar F, Bergsland E, Ngai J, Holmgren E, Wang J, Hurwitz H (2007) Arterial thromboembolic events in patients with metastatic carcinoma treated with chemotherapy and bevacizumab. J Natl Cancer Inst 99(16):1232-1239. doi: 10.1093/jnci/djm086 (Pubitemid 47299901)
-
(2007)
Journal of the National Cancer Institute
, vol.99
, Issue.16
, pp. 1232-1239
-
-
Scappaticci, F.A.1
Skillings, J.R.2
Holden, S.N.3
Gerber, H.-P.4
Miller, K.5
Kabbinavar, F.6
Bergsland, E.7
Ngai, J.8
Holmgren, E.9
Wang, J.10
Hurwitz, H.11
-
34
-
-
84867776380
-
Final results of an international retrospective observational study in patients with advanced breast cancer treated with oral vinorelbine-based chemotherapy
-
23060583 1:CAS:528:DC%2BC38Xhs1ygtbfO
-
Palomo AG, Glogowska I, Sommer H, Malamos N, Kilar E, Vega JM, Torrecillas L, Delozier T, Ettl J, Finek J (2012) Final results of an international retrospective observational study in patients with advanced breast cancer treated with oral vinorelbine-based chemotherapy. Anticancer Res 32(10):4539-4545
-
(2012)
Anticancer Res
, vol.32
, Issue.10
, pp. 4539-4545
-
-
Palomo, A.G.1
Glogowska, I.2
Sommer, H.3
Malamos, N.4
Kilar, E.5
Vega, J.M.6
Torrecillas, L.7
Delozier, T.8
Ettl, J.9
Finek, J.10
-
35
-
-
83355163402
-
Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancer
-
10.1200/JCO.2010.33.9101 22025143 10.1200/JCO.2010.33.9101 1:CAS:528:DC%2BC38XhtlKmtLc%3D
-
Stockler MR, Harvey VJ, Francis PA, Byrne MJ, Ackland SP, Fitzharris B, Van Hazel G, Wilcken NR, Grimison PS, Nowak AK, Gainford MC, Fong A, Paksec L, Sourjina T, Zannino D, Gebski V, Simes RJ, Forbes JF, Coates AS (2011) Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancer. J Clin Oncol 29(34):4498-4504. doi: 10.1200/JCO.2010.33.9101
-
(2011)
J Clin Oncol
, vol.29
, Issue.34
, pp. 4498-4504
-
-
Stockler, M.R.1
Harvey, V.J.2
Francis, P.A.3
Byrne, M.J.4
Ackland, S.P.5
Fitzharris, B.6
Van Hazel, G.7
Wilcken, N.R.8
Grimison, P.S.9
Nowak, A.K.10
Gainford, M.C.11
Fong, A.12
Paksec, L.13
Sourjina, T.14
Zannino, D.15
Gebski, V.16
Simes, R.J.17
Forbes, J.F.18
Coates, A.S.19
-
36
-
-
84878765775
-
Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer
-
10.1007/s10549-012-2288-x 23104222 10.1007/s10549-012-2288-x 1:CAS:528:DC%2BC38XhslyltbnI
-
Blum JL, Barrios CH, Feldman N, Verma S, McKenna EF, Lee LF, Scotto N, Gralow J (2012) Pooled analysis of individual patient data from capecitabine monotherapy clinical trials in locally advanced or metastatic breast cancer. Breast Cancer Res Treat 136(3):777-788. doi: 10.1007/s10549-012-2288-x
-
(2012)
Breast Cancer Res Treat
, vol.136
, Issue.3
, pp. 777-788
-
-
Blum, J.L.1
Barrios, C.H.2
Feldman, N.3
Verma, S.4
McKenna, E.F.5
Lee, L.F.6
Scotto, N.7
Gralow, J.8
|